136 related articles for article (PubMed ID: 30141571)
41. [Hepatitis C infections in dialyzed patients].
Podlasin RB
Przegl Epidemiol; 2005; 59(2):541-7. PubMed ID: 16190565
[TBL] [Abstract][Full Text] [Related]
42. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
[TBL] [Abstract][Full Text] [Related]
43. A review of direct-acting antivirals for the treatment of hepatitis C in patients with advanced chronic kidney disease.
Maruyama A; Partovi N; Yoshida EM; Erb SR; Azalgara VM; Hussaini T
Nephrol Dial Transplant; 2017 Jan; 32(1):35-41. PubMed ID: 26481484
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis.
Rocha CM; Perez RM; Ferreira AP; Carvalho-Filho RJ; Pace FH; Silva IS; Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
Liver Int; 2006 Apr; 26(3):305-10. PubMed ID: 16584392
[TBL] [Abstract][Full Text] [Related]
45. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
[TBL] [Abstract][Full Text] [Related]
46. Sofosbuvir and simeprevir in hepatitis C genotype 1-patients with end-stage renal disease on haemodialysis or GFR <30 ml/min.
Nazario HE; Ndungu M; Modi AA
Liver Int; 2016 Jun; 36(6):798-801. PubMed ID: 26583882
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
Lin MV; Sise ME; Pavlakis M; Amundsen BM; Chute D; Rutherford AE; Chung RT; Curry MP; Hanifi JM; Gabardi S; Chandraker A; Heher EC; Elias N; Riella LV
PLoS One; 2016; 11(7):e0158431. PubMed ID: 27415632
[TBL] [Abstract][Full Text] [Related]
48. Hepatitis C in dialysis units: the Saudi experience.
Karkar A
Hemodial Int; 2007 Jul; 11(3):354-67. PubMed ID: 17576302
[TBL] [Abstract][Full Text] [Related]
49. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Miyasaka M
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
[TBL] [Abstract][Full Text] [Related]
50. [Viral hepatitis C in patients with renal disease].
Contreras AM
Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S88-92. PubMed ID: 12712863
[TBL] [Abstract][Full Text] [Related]
51. New approaches in the therapy of hepatitis C in dialysis patients.
Sikole A; Dzekova P; Asani A; Amitov V; Selim G; Gelev S; Polenakovic M
Prilozi; 2008 Dec; 29(2):155-64. PubMed ID: 19259044
[TBL] [Abstract][Full Text] [Related]
52. Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis.
Goel A; Bhadauria DS; Kaul A; Prasad N; Gupta A; Sharma RK; Rai P; Aggarwal R
Nephrology (Carlton); 2017 Sep; 22(9):706-711. PubMed ID: 27286895
[TBL] [Abstract][Full Text] [Related]
53. Hepatitis C infection and the patient with end-stage renal disease.
Fabrizi F; Poordad FF; Martin P
Hepatology; 2002 Jul; 36(1):3-10. PubMed ID: 12085342
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis B and C virus infections among patients with end stage renal disease in a low-resourced hemodialysis center in Vietnam: a cross-sectional study.
Duong CM; Olszyna DP; McLaws ML
BMC Public Health; 2015 Feb; 15():192. PubMed ID: 25886623
[TBL] [Abstract][Full Text] [Related]
55. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.
Pereira BJ; Natov SN; Bouthot BA; Murthy BV; Ruthazer R; Schmid CH; Levey AS
Kidney Int; 1998 May; 53(5):1374-81. PubMed ID: 9573555
[TBL] [Abstract][Full Text] [Related]
56. [Hepatitis C virus and chronic progressive kidney disease].
Kes P; Slavicek J
Acta Med Croatica; 2009 Dec; 63(5):431-6. PubMed ID: 20198903
[TBL] [Abstract][Full Text] [Related]
57. Rationale for treating hepatitis C virus infection in patients with mild to moderate chronic kidney disease.
Ridruejo E; Mendizabal M; Silva MO
Hemodial Int; 2018 Apr; 22 Suppl 1():S97-S103. PubMed ID: 29694730
[TBL] [Abstract][Full Text] [Related]
58. Chronic hepatitis C.
Sherlock DS
Dis Mon; 1994 Mar; 40(3):117-96. PubMed ID: 7513276
[TBL] [Abstract][Full Text] [Related]
59. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
Fabrizi F; Martin P; Messa P
Kidney Int; 2016 May; 89(5):988-994. PubMed ID: 27083277
[TBL] [Abstract][Full Text] [Related]
60. Treatment of chronic hepatitis C in hemodialysis patients.
Berenguer M
Hepatology; 2008 Nov; 48(5):1690-9. PubMed ID: 18972442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]